Market Access News | pharmaphorum

Saturday 7 February 2026

News

News

Trump gives pharma ultimatum on most favoured nation pricing

Trump gives pharma ultimatum on most favoured nation pricing

President Trump has given 17 pharma companies until 29th September to commit to providing lower prices "to every single Medicaid patient."

News

CDER director George Tidmarsh

Tidmarsh to stand in for Prasad's role at CBER

Following Vinay Prasad's abrupt departure as CBER director, FDA has asked CDER head George Tidmarsh to take on both roles while a successor is sought.

News

Dr Sam Roberts, chief executive of NICE

NICE CEO to step down by year-end

Sam Roberts is stepping down from the role of NICE CEO to support her children through a difficult time, and a search for her replacement is underway.

News

Venclexta box and pill bottle

AbbVie files to move Venclexta combo into the CLL front line

AbbVie has filed for FDA approval of a new front-line therapy for chronic lymphocytic leukaemia that it thinks could be 'practice changing."

News

Vinay Prasad

Vinay Prasad abruptly departs from the FDA

The disruption at the FDA continues with the departure of CBER director Vinay Prasad, less than three months after taking on the role.

News

Von der Leyen and Trump

Pharma tariffs set to arrive with US-EU trade deal

After some initial confusion, it has been confirmed that the 15% tariff rate on US imports from the EU will extend to pharmaceuticals.